Yenidoğanda Kanamalara Yaklaşım
Synopsis
The neonatal hemostatic system operates in a physiological balance distinct from adults in terms of platelet function, coagulation factors, and fibrinolytic mechanisms. While platelet counts are generally within normal limits in healthy neonates, prothrombin time (PT) and activated partial thromboplastin time (aPTT) are physiologically prolonged due to low levels of vitamin K-dependent factors and anticoagulant proteins. When approaching a neonate with bleeding, cardiorespiratory stability must be established first, followed by an etiological investigation categorizing the infant's general condition as sick or healthy. Detailed history, physical examination, complete blood count, peripheral blood smear, coagulation panel, D-dimer, factor levels, and mixing tests play a critical role in the diagnostic process. Thrombocytopenia, the most common hemostatic disorder, can develop due to conditions such as sepsis, asphyxia, neonatal alloimmune (NAIT), or autoimmune (NOIT) thrombocytopenia, requiring appropriate platelet transfusion based on the clinical state. In hemorrhagic disease of the newborn occurring in infants without vitamin K prophylaxis, parenteral vitamin K, fresh frozen plasma, or prothrombin complex concentrate are administered. In cases of rare congenital factor deficiencies (such as Hemophilia A/B, Factor XIII deficiency) and disseminated intravascular coagulation (DIC), etiology-targeted blood product and factor replacements are performed, whereas maintaining hemodynamic stability and adequate cerebral perfusion is essential to prevent life-threatening intraventricular hemorrhage in premature infants.
References
Strauss T, Sidlik-Muskatel R, Kenet G. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med. 2011;16(6):301-4. doi: 10.1016/j.siny.2011.07.001
Saxonhouse MA, Garner R, Mammel L, et al. Closure times measured by the platelet function analyzer PFA-100 are longer in neonatal blood compared to cord blood samples. Neonatology. 2010;97:242-9. doi: 10.1159/000253755
Chakravorty S, Roberts I. How I manage neonatal thrombocytopenia. Br J Haematol. 2012;156:155-62. doi: 10.1111/j.1365-2141.2011.08892.x
Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165-72
Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood. 1988;72:1651-7
Kolindewala JK, Das BK, Dube RK, et al. Blood fibrinolytic activity in neonates: effect of period of gestation, birth weight, anoxia and sepsis. Indian Pediatr. 1987;24:1029-33
Schulte R, Jordan LC, Morad A, et al. Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth. Pediatr Neurol. 2014;50:564-8. doi: 10.1016/j.pediatrneurol.2014.02.013
Shapiro AD, Jacobson LJ, Armon ME, et al. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr. 1986;109:675-80. doi: 10.1016/s0022-3476(86)80241-4
Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed. 2003;88:359-64. doi: 10.1136/fn.88.5.f359
Bussel J, Kaplan C, McFarland J. Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. The Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1991;65:631-4
Peterson JA, McFarland JG, Curtis BR, et al. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161:3-14. doi: 10.1111/bjh.12235
VanVooren DM, Bradshaw WT, Blake SM. Disseminated Intravascular Coagulation in the Neonate. Neonatal Netw. 2018;37:205-11. doi: 10.1891/0730-0832.37.4.205
Leung KKY, Hon KL, Yeung A, et al. Congenital infections in Hong Kong: an overview of TORCH. Hong Kong Med J. 2020;26:127-38. doi: 10.12809/hkmj198287
Neumann A, Žižka Z, Koucký M, et al. Fetal and neonatal alloimmune thrombocytopenia. Ceska Gynekol. 2018;83:448-51
Sola MC. Evaluation and treatment of severe and prolonged thrombocytopenia in neonates. Clin Perinatol. 2004;31:1-14. doi: 10.1016/j.clp.2004.03.014
Cremer M, Sola-Visner M, Roll S, et al. Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion. 2011;51(12):2634-41. doi: 10.1111/j.1537-2995.2011.03208.x
Carr R, Kelly AM, Williamson LM. Neonatal thrombocytopenia and platelet transfusion - a UK perspective. Neonatology. 2015;107:1-7. doi: 10.1159/000365163
Bussel J. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost. 2009;7 Suppl 1:253-7. doi: 10.1111/j.1538-7836.2009.03380.x.
Ballin A, Andrew M, Ling E, et al. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr. 1988;112:789-92. doi: 10.1016/s0022-3476(88)80705-4
Araki S, Shirahata A. Vitamin K Deficiency Bleeding in Infancy. Nutrients. 2020;12:780. doi: 10.3390/nu12030780
Phillippi JC, Holley SL, Morad A, et al. Prevention of Vitamin K Deficiency Bleeding. J Midwifery Womens Health. 2016;61:632-636. doi: 10.1111/jmwh.12470
Bör O, Akgün N, Yakut A, et al. Late hemorrhagic disease of the newborn. Pediatr Int. 2000;42:64-6. doi: 10.1046/j.1442-200x.2000.01173.x
Zeng L, Choonara I, Zhang L, et al. Effectiveness of prothrombin complex concentrate (PCC) in neonates and infants with bleeding or risk of bleeding: a systematic review and meta-analysis. Eur J Pediatr. 2017;176:581-9. doi: 10.1007/s00431-017-2877-0
Moorehead PC, Chan AKC, Lemyre B, et al. A Practical Guide to the Management of the Fetus and Newborn With Hemophilia. Clin Appl Thromb Hemost. 2018;24(9_suppl):29S-41S. doi: 10.1177/1076029618807583
Rajagopal R, Thachil J, Monagle P. Disseminated intravascular coagulation in paediatrics. Arch Dis Child. 2017;102:187-193. doi: 10.1136/archdischild-2016-311053
Haley KM, Recht M, McCarty OJ. Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system. Pediatr Res. 2014;76:230-7. doi: 10.1038/pr.2014.87
Özek E, Kersin SG. Intraventricular hemorrhage in preterm babies. Turk Pediatri Ars. 2020;55:215-221. doi: 10.14744/TurkPediatriArs.2020.66742